InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Tvardi Therapeutics, Inc.

TVRD Clue Score27
United States Fiscal year ends December CIK 0001346830
$1.03 -4.63% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.03 −92.63% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.1Operating income−58.4Net income−57.3Fiscal year 2017Revenue0.9 +959.3%Operating income−59.5Net income−58.1Fiscal year 2018Revenue13.5 +1,378.5%Operating income−77.4Net income−74.0EPS, diluted−2.06Fiscal year 2019Revenue19.9 +47.6%Operating income−111.7Net income−106.4EPS, diluted−2.49Fiscal year 2020Revenue135.1 +579.3%Operating income5.4Net income8.4EPS, diluted0.18Fiscal year 2021Revenue23.0 −83.0%Operating income−89.1Net income−88.4 −1,151.6%EPS, diluted−1.74Fiscal year 2022Revenue41.9 +81.8%Operating income−87.5Net income−85.5EPS, diluted−19.12Fiscal year 2023Revenue21.0 −49.9%Operating income−121.5Net income−118.5EPS, diluted−26.26Fiscal year 2024Revenue7.1 −66.0%Operating income−28.1Net income−29.4EPS, diluted−11.42Fiscal year 2025Operating income−26.7Net income−18.2EPS, diluted−3.26
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 0.9 13.5 19.9 135.1 23.0 41.9 21.0 7.1 n/a
Growth +959.3% +1,378.5% +47.6% +579.3% −83.0% +81.8% −49.9% −66.0%
Operating income −58.4 −59.5 −77.4 −111.7 5.4 −89.1 −87.5 −121.5 −28.1 −26.7
Net income −57.3 −58.1 −74.0 −106.4 8.4 −88.4 −85.5 −118.5 −29.4 −18.2
Growth −1,151.6%
EPS, diluted n/a n/a −2.06 −2.49 0.18 −1.74 −19.12 −26.26 −11.42 −3.26

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−67,907.0%Net margin−66,604.7%Free cash flow margin−55,927.9%Fiscal year 2017Operating margin−6,529.6%Net margin−6,380.4%Free cash flow margin−6,024.7%Fiscal year 2018Operating margin−574.5%Net margin−549.5%Free cash flow margin−166.1%Fiscal year 2019Operating margin−561.6%Net margin−534.9%Free cash flow margin−549.3%Fiscal year 2020Operating margin4.0%Net margin6.2%Free cash flow margin−4.3%Fiscal year 2021Operating margin−386.8%Net margin−384.1%Free cash flow margin−261.1%Fiscal year 2022Operating margin−209.1%Net margin−204.2%Free cash flow margin−188.2%Fiscal year 2023Operating margin−579.4%Net margin−565.2%Free cash flow margin−450.5%Fiscal year 2024Operating margin−393.8%Net margin−411.9%Free cash flow margin−271.1%Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −67,907.0% −6,529.6% −574.5% −561.6% 4.0% −386.8% −209.1% −579.4% −393.8% n/a
Net margin −66,604.7% −6,380.4% −549.5% −534.9% 6.2% −384.1% −204.2% −565.2% −411.9% n/a
Free cash flow margin −55,927.9% −6,024.7% −166.1% −549.3% −4.3% −261.1% −188.2% −450.5% −271.1% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−47.4Capital expenditure−0.7Free cash flow−48.1Fiscal year 2017Operating cash flow−54.8Capital expenditure−0.1Free cash flow−54.9Fiscal year 2018Operating cash flow−22.3Capital expenditure−0.1Free cash flow−22.4Fiscal year 2019Operating cash flow−109.2Capital expenditure−0.0Free cash flow−109.2Fiscal year 2020Operating cash flow−5.5Capital expenditure−0.3Free cash flow−5.8Fiscal year 2021Operating cash flow−60.1Capital expenditure−0.0Free cash flow−60.1Fiscal year 2022Operating cash flow−78.7Capital expenditure−0.0Free cash flow−78.8Fiscal year 2023Operating cash flow−92.1Capital expenditure−2.4Free cash flow−94.5Fiscal year 2024Operating cash flow−18.3Capital expenditure−1.0Free cash flow−19.4Fiscal year 2025Operating cash flow−23.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −47.4 −54.8 −22.3 −109.2 −5.5 −60.1 −78.7 −92.1 −18.3 −23.5
Capital expenditure −0.7 −0.1 −0.1 −0.0 −0.3 −0.0 −0.0 −2.4 −1.0 n/a
Free cash flow −48.1 −54.9 −22.4 −109.2 −5.8 −60.1 −78.8 −94.5 −19.4 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash12.1Shareholders’ equity50.7Fiscal year 2017Cash9.4Shareholders’ equity86.8Fiscal year 2018Cash15.1Shareholders’ equity133.6Fiscal year 2019Cash18.3Shareholders’ equity186.7Fiscal year 2020Cash31.7Shareholders’ equity249.0Fiscal year 2021Cash13.5Shareholders’ equity227.5Fiscal year 2022Cash63.7Shareholders’ equity158.8Fiscal year 2023Cash51.8Shareholders’ equity−62.1Fiscal year 2024Cash31.6Shareholders’ equity−91.1Fiscal year 2025Cash20.7Shareholders’ equity20.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.1 9.4 15.1 18.3 31.7 13.5 63.7 51.8 31.6 20.7
Shareholders’ equity 50.7 86.8 133.6 186.7 249.0 227.5 158.8 −62.1 −91.1 20.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
0.1 0.9 13.5 19.9 135.1 23.0 41.9 21.0 7.1 n/a
Growth +959.3% +1,378.5% +47.6% +579.3% −83.0% +81.8% −49.9% −66.0%
n/a n/a n/a n/a n/a 0.0 n/a n/a n/a n/a
49.3 48.5 75.5 113.8 107.9 82.7 91.9 108.5 23.7 18.0
9.2 11.9 15.3 17.7 21.8 29.4 30.3 27.8 4.5 8.7
−58.4 −59.5 −77.4 −111.7 5.4 −89.1 −87.5 −121.5 −28.1 −26.7
Growth −1,754.3%
−57.7 −58.3 −74.4 −107.2 7.7 −88.4 −85.5 −118.5 −71.3 n/a
−0.5 −0.2 −0.4 −0.8 −0.7 0.0 0.0 0.0 0.0 0.0
−57.3 −58.1 −74.0 −106.4 8.4 −88.4 −85.5 −118.5 −29.4 −18.2
Growth −1,151.6%
Per share
n/a n/a −2.06 −2.49 0.18 −1.74 −19.12 −26.26 −11.42 −2.46
n/a n/a −2.06 −2.49 0.18 −1.74 −19.12 −26.26 −11.42 −3.26
Growth −1,066.7%
27.3 31.2 35.9 42.7 47.4 50.7 4.5 4.5 2.6 7.4
27.3 31.2 35.9 42.7 47.9 50.7 4.5 4.5 2.6 7.8
Growth +14.4% +15.0% +18.9% +12.3% +5.9% −91.2% +0.9% −43.0% +202.3%

† The diluted share count jumps at 2022 and 2024 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 18.5% a year over five years.
  • Operating margin is up 167.8 points on five years ago, at -393.8%.
  • A net loss in 9 of 10 years on file.